Merit Medical Systems, Inc. provided earnings guidance for the Fiscal Year 2022. For the period, the company expects Net revenue in the range of $1.117 billion to $1.140 billion, representing an increase of approximately 4% to 6% year-over-year, as compared to net revenue of $1.075 billion for the twelve months ended December 31, 2021. GAAP net income in the range of $75.4 million to $84.0 million, or $1.30 to $1.45 per diluted share, compared to GAAP net income of $48.5 million, or $0.84 per diluted share, for the twelve months ended December 31, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
81.5 USD | -0.51% | -0.98% | +7.29% |
05-16 | Merit Medical Elects Silvia M. Perez as New Director | CI |
05-15 | Merit Medical Systems Appoints Joe Wright as President | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.29% | 4.76B | |
-7.38% | 181B | |
-0.46% | 108B | |
-6.98% | 66.12B | |
+2.65% | 50.65B | |
+5.27% | 43.11B | |
+6.10% | 40.74B | |
+19.92% | 31.6B | |
+15.82% | 25.56B | |
-7.00% | 24.16B |
- Stock Market
- Equities
- MMSI Stock
- News Merit Medical Systems, Inc.
- Merit Medical Systems, Inc. Provides Earnings Guidance for the Fiscal Year 2022